Dose-Dependent Effects of Dihydronicotinamide Riboside on Human Engineered Skeletal Muscle Development
ACS Biomaterials Science & Engineering · 2026
DOI: 10.1021/acsbiomaterials.5c02051 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Ashwin Venkateshvaran und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cell Science and Regenerative Medicine (InStem), Bangalore Life Science Cluster, Bengaluru 560065, India. Hauptthemen laut MEDLINE: Muscle, Skeletal, Muscle Development, Tissue Engineering, Niacinamide. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Ministry of Science and Technology, India, Mitosciences LLC.
Abstract (Originalsprache)
Nicotinamide adenine dinucleotide (NAD+) precursors are explored for metabolic and longevity interventions; however, their impact on human skeletal muscle development remains unclear due to limitations of conventional 2D cultures and animal models. Here, we employed three-dimensional engineered skeletal muscle tissues derived from primary human myoblasts to investigate dose-dependent effects of dihydronicotinamide riboside (NRH), a potent NAD+ precursor. Moderate NRH exposure (25 μM) enhanced myogenic differentiation and fusion without affecting viability, aligning with physiologically relevant plasma levels. In contrast, a sustained high NRH concentration (500 μM) increased the myotube number and fast-twitch fiber area but disrupted sarcomeric organization, acetylcholine receptor clustering, and calcium signaling, with transcriptomic profiling revealing downregulation of myogenesis and metabolic pathways. These findings demonstrate that NRH exerts biphasic effects on human skeletal muscle differentiation and maturation, underscoring the utility of 3D engineered muscle tissues as a human-relevant platform to evaluate therapeutic and toxic doses of NAD+-boosting compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Stem Cell Science and Regenerative Medicine (InStem), Bangalore Life Science Cluster, Bengaluru 560065, India.
- Tata Institute for Genetics and Society (TIGS), InStem Building, NCBS Campus, GKVK Post, Bellary Road, Bengaluru 560065, India.
- Regional Centre for Biotechnology (RCB), NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Highway, Faridabad, Haryana 121001, India.
- Manipal Academy of Higher Education (MAHE), Tiger Circle Road, Madhav Nagar, Manipal, Udupi District, Karnataka 576104, India.
- University of Texas Southwestern Medical Center (UTSW), 6000 Harry Hines Blvd, Dallas, Texas 75235, United States.
- MitoPower Inc, Palo Alto, California 934303, United States.
ORCID-Profile: Swarang Sachin Pundlik, Alok Barik, Arvind Ramanathan
Förderung
- Indian Council of Medical Research
- Department of Biotechnology, Ministry of Science and Technology, India
- Mitosciences LLC
Zitieren
APA
Venkateshvaran, A., Pundlik, S. S., Suresh, Y., Hegde, A., Venkatesh, B., Dowari, S., Gogia, D., Rajalakshmi, S., Saha, P., Barik, A., Lal, H., Zachariah, N., Pranesh, G., Subramanian, G. M., & Ramanathan, A. (2026). Dose-Dependent Effects of Dihydronicotinamide Riboside on Human Engineered Skeletal Muscle Development. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c02051
Vancouver
Venkateshvaran A, Pundlik SS, Suresh Y, Hegde A, Venkatesh B, Dowari S, et al. Dose-Dependent Effects of Dihydronicotinamide Riboside on Human Engineered Skeletal Muscle Development. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.5c02051
BibTeX
@article{Venkateshvaran2026,
author = {Venkateshvaran, Ashwin and Pundlik, Swarang Sachin and Suresh, Yavanica and Hegde, Akshay and Venkatesh, Bhushan and Dowari, Sikhasmita and Gogia, Diksha and Rajalakshmi, Srujanika and Saha, Pushpita and Barik, Alok and Lal, Heera and Zachariah, Nikhil and Pranesh, Gautham and Subramanian, G Mani and Ramanathan, Arvind},
title = {Dose-Dependent Effects of Dihydronicotinamide Riboside on Human Engineered Skeletal Muscle Development},
journal = {ACS Biomaterials Science & Engineering},
year = {2026},
doi = {10.1021/acsbiomaterials.5c02051}
}
EUVIMED